Symmetron is an established boutique health economics and health outcomes research consultancy that helps companies realise and communicate the value of their drugs and devices. Our mission is to increase access to healthcare that saves lives and improves quality of life for people around the world.

We provide a full range of services for clients seeking market access and reimbursement in Europe, North America, Asia and Australia, including:

• Evidence development
• Health economic modelling
• Health technology assessment
• Statistical analysis of trial data
• Scientific writing
• Training and workshops

We have experienced significant success since 2008, achieving market access for dozens of healthcare products and launching several blockbuster pharmaceuticals. We have published over 100 scientific articles, expanded our core service offerings and enjoyed steady growth fueled by the reputation of our exceptional team.

Clients tell us they repeatedly return to us and refer us because of our:

• Team stability – ‘With Symmetron you know what team you're going to get, so you can always give a solid recommendation to others’
• Integrity, honesty and transparency – ‘It’s great to be able to talk to someone honest and practiced’
• Flexibility, agility and pragmatism – ‘Team thinks out of the box and can move quickly’
• Professionalism and technical expertise – ‘Always delivered rigorous research and rock-solid timely results’
• Partnership – ‘Symmetron felt more like an extension of our own team’